» Articles » PMID: 33781385

Early Postmortem Mapping of SARS-CoV-2 RNA in Patients with COVID-19 and the Correlation with Tissue Damage

Abstract

Clinical observations indicate that COVID-19 is a systemic disease. An investigation of the viral distribution within the human body and its correlation with tissue damage can aid in understanding the pathophysiology of SARS-CoV-2 infection. We present a detailed mapping of the viral RNA in 61 tissues and organs of 11 deceased patients with COVID-19. The autopsies were performed within the early postmortem interval (between 1.5 and 15 hr, mean: 5.6 hr) to minimize the bias due to viral RNA and tissue degradation. Very high viral loads (>10copies/ml) were detected in most patients' lungs, and the presence of intact viral particles in the lung tissue could be verified by transmission electron microscopy. Interestingly, viral RNA was detected throughout various extrapulmonary tissues and organs without visible tissue damage. The dissemination of SARS-CoV-2-RNA throughout the body supports the hypothesis that there is a maladaptive host response with viremia and multiorgan dysfunction.

Citing Articles

Hemophagocytosis of the Hilar Pulmonary Lymph Nodes Is a More Sensitive Indicator of the Severity of COVID-19 Disease than Bone Marrow Hemophagocytosis.

Jusovic-Stocanin A, Kaemmerer E, Ihle H, Autsch A, Kleemann S, Sanft J Diseases. 2024; 12(10).

PMID: 39452484 PMC: 11506861. DOI: 10.3390/diseases12100241.


Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook.

Kruger A, Joffe D, Lloyd-Jones G, Khan M, Salamon S, Laubscher G Semin Thromb Hemost. 2024; 51(3):256-271.

PMID: 39348850 PMC: 11906225. DOI: 10.1055/s-0044-1790603.


Prolonged exposure to lung-derived cytokines is associated with activation of microglia in patients with COVID-19.

Grant R, Poor T, Sichizya L, Diaz E, Bailey J, Soni S JCI Insight. 2024; 9(8).

PMID: 38502186 PMC: 11141878. DOI: 10.1172/jci.insight.178859.


SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset.

Tomasicchio M, Jaumdally S, Wilson L, Kotze A, Semple L, Meier S Am J Respir Crit Care Med. 2024; 209(7):840-851.

PMID: 38226855 PMC: 10995573. DOI: 10.1164/rccm.202308-1438OC.


Uncovering a unique pathogenic mechanism of SARS-CoV-2 omicron variant: selective induction of cellular senescence.

Hornung F, Kose-Vogel N, Jourdan Le Saux C, Hader A, Herrmann L, Schulz L Aging (Albany NY). 2023; 15(23):13593-13607.

PMID: 38095608 PMC: 10756098. DOI: 10.18632/aging.205297.


References
1.
Li H, Liu L, Zhang D, Xu J, Dai H, Tang N . SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020; 395(10235):1517-1520. PMC: 7164875. DOI: 10.1016/S0140-6736(20)30920-X. View

2.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

3.
Lenman A, Muller S, Nygren M, Frangsmyr L, Stehle T, Arnberg N . Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells. J Virol. 2011; 85(24):13420-31. PMC: 3233144. DOI: 10.1128/JVI.06088-11. View

4.
Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

5.
Edler C, Schroder A, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F . Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med. 2020; 134(4):1275-1284. PMC: 7271136. DOI: 10.1007/s00414-020-02317-w. View